Cargando…
The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel
BACKGROUND: Dexamethasone (DEX) has been routinely used as a pre-treatment in the clinical application of paclitaxel (PTX) to treat ovarian cancer. However, PTX-induced apoptosis might be inhibited by DEX. This study was undertaken to investigate the effects of DEX on the apoptosis induced by PTX. M...
Autores principales: | Hou, Wenjing, Guan, Jianhua, Lu, Huan, Dong, Qian, Han, Yuhong, Zhang, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200216/ https://www.ncbi.nlm.nih.gov/pubmed/25297825 http://dx.doi.org/10.1186/s13048-014-0089-z |
Ejemplares similares
-
Retraction Note: The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel
por: Hou, Wenjing, et al.
Publicado: (2015) -
Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
por: Gong, Li-Hua, et al.
Publicado: (2014) -
Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway
por: Jiang, Luo, et al.
Publicado: (2020) -
MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3
por: Zhao, Shuzhen, et al.
Publicado: (2021) -
Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
por: Scharer, Christopher D, et al.
Publicado: (2008)